Mkts

The Oncology Institute, Inc.

NASDAQ: TOI
$6.74-0.20 (-2.88%)
As of Nov 4, 7:00 PM ET

Key statistics

Day range
6.697.01
52-week range
2.327.13
Today
Open6.88
Previous close6.74
Volume983.0K
Valuation
Market cap512.91M
P/E ratio—
EPS (TTM)-0.45
Income & risk
Dividend / yield—
Beta0.24
Avg volume1.69M
Discussion

TOI News

Stories mentioning TOI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue147,441141,957136,564119,802104,406100,26799,90198,578
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin28,21228,04025,25126,90725,37624,85826,64627,872
Total Operating Expenses
Operating Income (Loss)(6,513)(6,907)(8,054)(11,211)(9,911)(11,929)(13,853)(16,364)
Interest Income
Interest Expense
Other Expense791.00249.00(403.00)(19.00)(752.00)(261.00)(55.00)(117.00)
Pretax Income(2,492)(7,508)(16,504)(17,140)(19,585)(13,182)(16,113)(15,479)
Tax Provision0.000.000.00(131.00)0.000.000.000.00
Net Income (Loss)(2,492)(7,508)(16,504)(17,009)(19,585)(13,182)(16,113)(15,479)
Earnings Per Share (Basic)(0.02)(0.08)(0.14)(0.15)(0.21)(0.18)(0.18)(0.17)
Earnings Per Share (Diluted)(0.02)(0.08)(0.14)(0.15)(0.21)(0.18)(0.18)(0.17)
Weighted Average Shares Outstanding (Basic)101,80292,38997,47593,20477,09975,04475,52574,748
Weighted Average Shares Outstanding (Diluted)101,80292,38997,47593,20477,09975,04475,52574,748

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TOI

The Oncology Institute, Inc. (NASDAQ: TOI) is a stock listed on the Nasdaq Stock Market under the ticker symbol TOI. It last traded at $6.74 (Nov 4, 2026, 7:00 PM ET), down 2.9% on the day. That gives The Oncology Institute a market capitalisation of $512.9M.

Over the past 52 weeks TOI has traded between $2.32 and $7.13.

Revenue for the quarter ended Mar 31, 2026 was $147.4M; a net loss of $2.5M. Revenue was up 41.2% from $104.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$147.4M-$2.5M-1.7%
Dec 31, 2025$142.0M-$7.5M-5.3%
Sep 30, 2025$136.6M-$16.5M-12.1%
Jun 30, 2025$119.8M-$17.0M-14.2%

From The Oncology Institute’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…